Zobrazeno 1 - 10
of 35
pro vyhledávání: '"R. Ibeas"'
Autor:
R.M. Hernández, Sara Morales, J. Moreno, Sandra Santasusagna, Jordi Canals, Joan J. Castellano, Concha Muñoz, R. Ibeas, Francisco Ramos Martínez, I. Moreno, Mariano Monzo, Alfons Navarro
Publikováno v:
Annals of Oncology. 28:v193-v194
Publikováno v:
Computer Applications in Engineering Education. 2:239-243
In this article we describe the development of a C++ program for Windows designed to aid the setting up of a VSAT communications network. The network's purpose is to perform the relevant radio link calculations, taking into consideration aspects such
Autor:
E. Saigí, M. Nogué, R. Ibeas, Joan Carles, K. Villadiego, Miquel Domènech, Inmaculada Guasch, C. Pérez
Publikováno v:
Oncology. 59(1)
Introduction: Bladder cancer is a frequently occurring tumour in Spain and usually affects elderly patients with renal impairment. The development of new combination therapies for such patients is thus of vital importance. Patients and Methods: Betwe
Publikováno v:
Primary Care Diabetes. 1:232
Autor:
A. Navarro, R. Hernandez-Borlan, Rosa Artells, R. Ibeas-Rollan, O. Etxaniz, I. Moreno-Solorzano, B. Gel-Moreno, J. Tello, M. Monzo-Planella, J. Moreno-Solorzano
Publikováno v:
European Journal of Cancer Supplements. 5:253
Autor:
Jesús García-Foncillas, J. Moreno, M. Monzo-Planella, Alfons Navarro, Rosa Artells, M. Miguel, Eva Bandrés, R. Ibeas, Bernat Gel, Irene Moreno, Alfonso Gurpide
Publikováno v:
Journal of Clinical Oncology. 25:10525-10525
10525 Background: Mature microRNAs (miRNA) are small RNA molecules that act as negative regulators of gene expression, either inhibiting mRNA by blocking its translation into protein or destroying it by RNA interference. Many miRNAs participate in es
Autor:
Alfons Navarro, E. Pou, I. Moreno, Francisco Ramos Martínez, J. M. Vila, J. Moreno, M. Pinuaga, J. Sole Monne, R. Ibeas, Mariano Monzo
Publikováno v:
Journal of Clinical Oncology. 22:3677-3677
3677 Background: Oxaliplatin damages DNA, leading to apoptosis. XPD, XPA, ERCC1 and XPG/ERCC1 are involved in DNA repair, and polymorphic variants in these genes can influence the efficacy of oxaliplatin. We analyzed SNPs in these genes and correlate
Autor:
I. Moreno, Rosa Artells, G. Torres, J. M. Vila, J. Moreno, A. Alcaide, J. Pie, M. Monzo, R. Ibeas, Francisco Ramos Martínez
Publikováno v:
European Journal of Cancer Supplements. 1:S79
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Prostate. 33:147-147